Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM)

Biomaterials

Volumn 25, Issue 21, 2004, Pages 5181-5189

  Feng, Si Shen ^a   Ruan, Gang ^a   Li, Qiu Tian ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

DCM, dichloromethane; DOPC, 1,2 Dioleoyl sn glycero 3 phosphocholine; Double emulsion process, water in oil in water double emulsion solvent extraction evaporation process; DPPG, 1,2 Dipalmitoyl sn glycero 3 (phospho rac (1 glycerol))

Indexed keywords

BIODEGRADATION; COMPOSITION; LIGHT SCATTERING; LIPIDS; POLYMERS; PORE SIZE; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPIC ANALYSIS;

BIODEGRADABLE POLYMERS; DRUG DELIVERY SYSTEMS; FLUORESCENCE SPECTROSCOPY; MICROENCAPSULATION;

DRUG PRODUCTS;

CHITOSAN; LIPOSOME; MICROSPHERE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLUORESCENCE SPECTROSCOPY; LIGHT SCATTERING; MICROENCAPSULATION; PRIORITY JOURNAL; SURFACE PROPERTY;

COATED MATERIALS, BIOCOMPATIBLE; CONTRACEPTIVE AGENTS; DIFFUSION; LIPOSOMES; MATERIALS TESTING; MICROSPHERES; PARTICLE SIZE; PHOSPHOLIPIDS; POLYMERS; SURFACE PROPERTIES;

EID: 1942454356     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.12.013     Document Type: Article

References (31)

1. Langer R. Perspectives. drug delivery-drugs on target Science. 293(5527):2001;58-59.
2. Panchagnula R. Pharmaceutical aspects of paclitaxel. Int J Pharm. 172(1-2):1998;1-15.
3. Langer R. Drug delivery and targeting. Nature. 392(6679):1998;5-10.
4. Lasic D.D. Liposomes. from physics to applications:1993;Elsevier, Amsterdam, New York.
5. ®) from nanospheres of biodegradable polymers. J Controlled Rel. 71(1):2001;53-69.
6. Wang F.J., Wang C.H. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. J Controlled Release. 81(3):2002;263-280.
7. Dass C.R., Burton M.A. Microsphere-mediated targeted gene therapy of solid tumors. Drug Deliv. 6(4):1999;243-252.
8. Fu K., Klibanov A.M., Langer R. Protein stability in controlled release systems. Nature Biotechnol. 18(1):2000;24-25.
9. Stenekes R.J.H., Loebis A.E., Fernandes C.M., Crommelin D.J.A., Hennink W.E. Controlled release of liposomes from biodegradable dextran microspheres. a novel delivery concept Pharm Res. 17(6):2000;690-695.
10. Machluf M., Apte R.N., RegeV O., Cohen S. Enhancing the immunogenicity of liposomal hepatitis B surface antigen (HBsAg) by controlling its delivery from polymeric microspheres. J Pharm Sci. 89(12):2000;1550-1557.
11. Vrancken MN, Clays DA. US Patent 3, 526, 906, 1970.
12. Dejaeger NC, Tavernier BH. British Patent 1, 405, 108, 1971.
13. Zhou S.B., Deng X.M., Li X.H. Investigation on a novel core-coated microspheres proteins delivery system. J Controlled Rel. 75(1-2):2001;27-36.
14. Singla A.K., Alka G., Deepika A. Paclitaxel and its formulations. Int J Pharm. 235(1-2):2002;179-192.
15. Tatou E., Mossiat C., Maupoil V., Gabrielle F., David M., Rochette L. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation. Pharmacology. 52:1996;1-7.
16. Dorr R.T. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother. 28:1994;S11-S14.
17. Fjallskog M.L., Frii L., Bergh J. Is cremophor, solvent for paclitaxel, cytotoxic? Lancet. 342:1993;876.
18. Schmitt-Sody M., Strieth S., Krasnici S., Sauer B., Schulze B., Teifel M., Michaelis U., Naujoks K., Dellian M. Neovascular targeting therapy. paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy Clin Cancer Res. 9(6):2003;2335-2341.
19. Kunstfeld R., Wickenhauser G., Michaelis U., Teifel M., Umek W., Naujoks K., Wolff K., Petzelbauer P. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermat. 120(3):2003;476-482.
20. Crosasso P., Ceruti M., Brusa P., Arpicco S., Dosio F., Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Rel. 63(1-2):2000;19-30.
21. Ceruti M., Crosasso P., Brusa P., Arpicco S., Dosio F., Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J Control Rel. 63(1-2):2000;141-153.
22. Feng SS, Mu L, Win KY, Huang GF. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 2004;11:413-24. [Invited paper].
23. Fonseca C., Simoes S., Gaspar R.E. Paclitaxel-loaded PLGA nanoparticles. preparation, physicochemical characterization and in vitro anti-tumoral activity J Controlled Rel. 83(2):2002;273-286.
24. Chen Z.Y., He C.Y., Ehrhardt A., Kay M.A. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high level transgene expression in vivo. Mol Therapy. 7(5):2003;162-168.
25. New R.R.C. Liposomes. a practical approach:1990;IRL Press, Oxford, New York, Tokyo.
26. Gregoriadis G. Liposome technology, vol. III. Boca Raton: CRC Press; 1984.
27. Ruan G., Feng S.S., Li Q.T. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Controlled Rel. 84(3):2002;151-160.
28. Kumar M.N.V.R. A review of chitin and chitosan applications. React Funct Polym. 46(1):2000;1-27.
29. Takeuchi H., Yamamoto H., Kawashima H. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 47(1):2001;39-54.
30. Ruan G., Feng S.S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials. 24(27):2003;5037-5044.
31. Fan L.T., Singh S.K. Controlled release. a quantitative treatment:1989;Springer, Berlin, New York.